The Recall Desk
ModerateFDA (Drugs)·D-0083-2021·Announced 2020-11-25

Milbar Recalls DCL Active Mattifying Cleanser Due to GMP Deviations

Milbar Laboratories is recalling 4,878 tubes of DCL Active Mattifying Cleanser due to Good Manufacturing Practice (GMP) deviations. The product was distributed nationwide and internationally.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II and is voluntary, with no reported illnesses or injuries in the source text, fitting the criteria for a moderate severity precautionary recall.

Plain-English summary

Milbar Laboratories, Inc. is voluntarily recalling 4,878 tubes of DCL Active Mattifying Cleanser (Salicylic Acid 2%), 125mL/4.2 fl.oz. The recall was initiated on October 9, 2020, and was classified as Class II by the FDA. The reason for the recall is Good Manufacturing Practice (GMP) deviations.

The affected product is identified by Lot # FW937 and an expiration date of June 2022. The product was distributed throughout the United States, including Puerto Rico, as well as internationally. The recall status is currently terminated.

Consumers who have this product should stop using it and contact the recalling firm for further instructions. The firm initiated this recall voluntarily.

The recalled product

Product
DCL Active Mattifying Cleanser (Salicylic Acid 2%), 125mL/4.2 fl.oz. Dermatologic Cosmetic Laboratories, East Haven, CT 06512 USA, UPC 357486509627
Manufacturer
Milbar Laboratories, Inc.
Category
Drug — Topical Dermatologic
Hazard
Affected units
4,878

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot # FW937
  • Exp. Date Jun-22

Distribution

Distributed in 1 state:

Part of a larger recall action

This product is one of 14 recalled by Milbar Laboratories, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 14 products in this recall →

Related recalls

Same manufacturer · Milbar Laboratories, Inc.

See all →

Same hazard · gmp deviation

See all →